Agostino Riva - Concepedia

Author

Agostino Riva

Also Known As

A Riva, A. Riva, Agostino Riva, Agostino Riva, for the ELVIS Study Group, Angela Giovanna Vidal Riva, Arianna Gabrieli, Bruno Cacopardo, Christian Garzoni, Ferdinando Giannattasio, Ioannis Theodorou

246

Publications

14.7K

Citations

H-Index

129

Concepts

All Affiliations

University of Milan Luigi Sacco Hospital ASST Fatebenefratelli Sacco Vir Biotechnology (Switzerland)University of Modena and Reggio Emilia

About

Agostino Riva is an author at University of Milan specializing in medicine, immunology, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	41	7.6K
2	Public Health	11	11	666
3	Health Sciences	2	2	102
4	Natural Sciences	1	1	21
5	Allergy	1	1	15

Agostino Riva

101

Publications

11.8K

Citations

H-Index

Page 1

	Year	Citations
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology Luca Piccoli, Young‐Jun Park, M. Alejandra Tortorici, Cell Structure-guided High-resolution SerologyVirus StructureImmunodominant SitesImmunologyReceptor (Biochemistry)	2020	1.6K
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift Elisabetta Cameroni, John E. Bowen, Laura E. Rosen, Nature VaccinationNeutralizing AntibodiesVaccine TargetHumoral ResponseImmunology	2021	1.2K
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 Matthew McCallum, Anna De Marco, Florian A. Lempp, Cell Viral PathogenesisImmunologyVirologyViral Structural ProteinMedicine	2021	998
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies Dami A. Collier, Anna De Marco, Isabella A.T.M. Ferreira, Nature VaccinationVaccine DevelopmentImmunologyVirologySars-cov-2 B.1.1.7	2021	711
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity Emma C. Thomson, Laura E. Rosen, James G. Shepherd, Cell	2021	652
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms M. Alejandra Tortorici, Martina Beltramello, Florian A. Lempp, Science Viral DiagnosticsImmunologyViral PathogenesisImmunodominanceImmunotherapeutics	2020	615
Broad betacoronavirus neutralization by a stem helix–specific human antibody Dora Pinto, Maximilian M. Sauer, Nadine Czudnochowski, Science	2021	416
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection Laura Montefusco, Moufida Ben Nasr, Francesca D’Addio, Nature Metabolism Glycometabolic ControlLong CovidViral PersistenceImmunologyVirology	2021	411
Results of Two Open-Label, Multicenter Phase II Studies of Docetaxel, Platinum Salts, and Trastuzumab in HER2-Positive Advanced Breast Cancer M. Pegram, Tadeusz Pieńkowski, Donald W. Northfelt, JNCI Journal of the National Cancer Institute	2004	271
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population Elisa Benetti, Rossella Tita, Ottavia Spiga, European Journal of Human Genetics	2020	267

Page 1